Video

Dr Stephen Silberstein Discusses Erenumab Use for Menstrual Migraine

If you only experience migraine with your period for a few days, it would be difficult to recommend taking a drug all the time, said Stephen Silberstein, MD, professor of neurology at Thomas Jefferson University and director of the Headache Center at Jefferson Health.

If you only experience migraine with your period for a few days, it would be difficult to recommend taking a drug all the time, said Stephen Silberstein, MD, professor of neurology at Thomas Jefferson University and director of the Headache Center at Jefferson Health.

Transcript:

The American Journal of Managed Care®(AJMC®): Results from STRIVE found erenumab is a safe and effective option for treating menstrual migraine. Do you think erenumab will be indicated for this condition in the near future?

Dr. Silberstein: There are 2 types of menstrual migraine. There's pure menstrual migraine when women only have migraine with their period and there's menstrual migraine that occurs at any other time. So if you only have migraine with your period for a couple days, I think it would be difficult to recommend taking a drug all the time just for a headache that only occurs 3 days a month. If you have menstrual migraine plus other migraine, and it's intractable, obviously, they should get treatment. There are other treatment options, short-term treatment options, for hormonal treatment for women with pure menstrual migraine.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Andrew Kuykendall, MD, Moffitt Cancer Center
Coral Omene, MD, PhD, sitting for a vieo interview
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Dirk Arnold, MD, PhD, medical director, Asklepios Tumour Biology Centre
Dr Brian Slomovitz
Dr Sheela Rao
Merrill H. Stewart, MD
Dr Margrit Wiesendanger
Coral Omene, MD, PhD, sitting for a vieo interview
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo